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Implantable cardioverter-defibrillators (ICDs) have a proven role in primary and secondary 
prevention of sudden death from ventricular arrhythmias. Transvenous ICD systems despite 
this proven benefit, have been plagued by lead problems including fracture, insulation breaks 
and  recalls;  and  issues  with  transvenous  access  including  pneumothorax  and  venous 
obstruction. Infected or fractured leads require full extraction which may require laser-assisted 
removal  which  carry  a  mortality  and  morbidity  risk.  Subcutaneous  ICDs  (S-ICD)  are  an 
exciting  recently  approved technology  providing  the  advantages  of  effective  shock rescue 
without need for transvenous leads. They function as essentially shock boxes without pacing 
capability  except  for  a  short  period  of  post  shock transcutaneous  pacing.  This  technology 
provides  an  emerging  option  especially  in  patient  groups  who  do  not  have  a  pacing 
indication,  have no venous access, patients at high infection risk, patients with no structural 
heart  disease  and  hereditary  arrhythmias;  and  patients  with  congenital  heart  disease  that 
precludes  transvenous  leads.  Patients  with  slow  monomorphic  ventricular  tachycardia 
consistently terminated by antitachycardia pacing are also not candidates for this therapy in 
evolution. In addition, S-ICDs do not have remote monitoring capability.                                 
The S-ICD system uses modified subcutaneous electrocardiography through either a primary, 
secondary,  or alternate  vector,  which detects  changes  in  ventricular  rate.  The heart  rate  is 
measured as the rolling average of 4 consecutive sensed intervals. Ventricular fibrillation (VF) 
is  diagnosed  when  18  of  24  consecutive  sensed  events  exceed  the  shock  zone  limit.
In this issue of the Indian Pacing and Electrophysiology Journal, Tekkatte et al [1] describe 
inappropriate therapies delivered from a subcutaneous ICD in their report titled "A Case of 
Inappropriate Therapies for Atrial Flutter From a Subcutaneous ICD". Inappropriate therapies 
were  delivered  three  times  in  response  to  atrial  flutter.  One  self-terminating  episode  of 
ventricular  fibrillation  was  not  detected.  After  failed  ablation,  more  aggressive  medical 
management  of  the  atrial  flutter  was  planned  with  Amiodarone  and  Bisoprolol.  Despite 
programming  changes  in  response,  which  included  increasing  the  VF  detection  rate,  and 
changing the vector for detection; the patient continued to get shocks from the device. Finally, 
a  transvenous  ICD was  implanted.                                                  
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Of note, the S-ICD device in this case was always programmed with one zone. Discriminator 
functions on the S-ICD are however possible only with dual zone programming into a shock 
zone  and  a  conditional  shock  zone.  There  are  no  discriminators  in  the  shock  zone. 
Discrimination  has 3 steps:  1- comparison of current  tachycardia  complex waveform with 
stored template acquired at rest (>50% = supraventricular tachycardia). 2- beat to beat analysis 
evaluates  for  polymorphic  or  monomorphic  relationship  (if  polymorphic  -  ventricular 
tachycardia,  if  monomorphic  -  algorithm  continues).  3  -  QRS  width  analysis  (wide  - 
ventricular tachycardia, Narrow - supraventricular tachycardia).                                      
There is early data now available regarding usefulness of these discriminators. In the START 
Study, Gold et al [2] showed 100% sensitivity and 98% specificity for VT and SVT with the 
S-ICD. Specificity was best with the S-ICD in a head-to-head comparison with transvenous 
discriminations  algorithms  from 3  different  manufacturers.  In  another  article  by  the  same 
group (now in press in the Heart Rhythm journal)  [3], 226 subjects (72%) with dual zone 
programming (which included a S-ICD discrimination algorithm) and 88 subjects (28%) with 
single zone programming were compared. The addition of a second shock zone with an active 
discrimination algorithm was strongly associated with a reduction in inappropriate shocks with 
the S-ICD system and did not result in prolongation of detection times or increased syncope. 
These data support the use of dual zone programming as a standard setting for S-ICD patients.
This discrimination algorithm however would not have helped in the reported case because it 
relies on comparing R wave to R wave. In the case study, flutter waves were oversensed as R 
waves and it is unlikely that they would match the template. The problem here was the far-
field sensing vectors  (8 cm shock coil  separating  sensing electrodes)  and the large flutter 
waves.  
Analogous to this case, in another patient with hypertrophic cardiomyopathy, we have seen 
flutter  waves sensed as ventricular fibrillation signals in a transvenous ICD. The lead was 
repositioned which is not an option with the S-ICD. In addition, chances of cross chamber 
sensing are likely to be less due to bipolar near - field sensing in both atrium and ventricle with 
transvenous system. Pre- implant ECG assessment is primarily for T wave to R wave ratio and 
not atrial  versus ventricular  ratio  and importantly  the patient  was not in flutter  at  time of 
assessment.
Anecdotal  case  reports  now  demonstrate  compatibility  with  transvenous  and  epicardial 
pacemakers  which  will  increase  the  clinical  utility  of  S-ICD despite  being  limited  in  not 
having  the  capabilities  of  bradycardia  pacing,  anti-tachycardia  pacing  and  cardiac 
resynchronization  therapy.  Superior  discrimination  algorithms  in  future  iterations  of  this 
device may help expand implant indications further. However, there may remain situations 
like in the reported case where it may not be possible to tackle oversensing of large atrial  
electrograms by programming changes in a S-ICD in its current form.                               
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